Drugs made in space “cooked real good,” says startup

Varda says its space factory performed “flawlessly.”

It took seven months longer than expected to get it home, but Varda Space Industries has finally retrieved the medication it manufactured in space — and according to the company’s analysis, the mission was a major success.

“The one-liner is…them space drugs cooked real good,” tweeted Delian Asparouhov, one of the California startup’s co-founders.

Space drugs: In June 2023, a SpaceX rocket deployed a first-of-its-kind spacecraft designed to autonomously synthesize a drug — the HIV-AIDS medication ritonavir — while in Earth’s orbit.

Varda had built the craft to demonstrate how “space factories” could autonomously produce products that are easier to manufacture in the absence of gravity, starting with certain pharmaceuticals but eventually expanding to fiber optic cables, semiconductors, and more.

“This is our first step in commercializing microgravity drug development.”

Varda Space Industries

Slow burn: The space factory was supposed to return to Earth about a month after launch, but issues with regulators delayed the homecoming until February 2024

Varda has now had time to study its space drugs and has shared a detailed report on the preprint server ChemRxiv. The short story, though, is that the ritonavir was successfully synthesized and remained stable throughout the reentry process.

“Our process and hardware performed flawlessly throughout in-orbit operations, reentry, and recovery operations,” tweeted Varda on March 20.

Looking ahead: Now that Varda has demonstrated that its space factory works as hoped, it’s eager to begin using the spacecraft to manufacture more space drugs.

“This is our first step in commercializing microgravity drug development,” tweeted Varda. “Our mission is to now enable cost-effective high-cadence access to enable next-generation therapeutics.”

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

AI can help predict whether a patient will respond to specific tuberculosis treatments
Instead of a one-size-fits-all treatment approach, AI could help personalize treatments for each patient to provide the best outcomes.
T-Minus: SpaceX’s military launch, a rocket family’s final flight, and more
Freethink’s weekly countdown of the biggest space news, featuring a new kind of military satellite, the solar eclipse, and more.
In a future with brain-computer interfaces like Elon Musk’s Neuralink, we may need to rethink freedom of thought
In a future with more “mind reading,” thanks to computer-brain interfaces, we may need to rethink freedom of thought.
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
Up Next
A digitally altered image of a cow with graphic illustrations representing chemistry and data overlaying a pastoral scene.
Subscribe to Freethink for more great stories